Highlights
1 patent
About
Innovative Combinations of Previously Approved Drugs
Pharma Two B is a clinical-stage pharmaceutical company that is developing differentiated and value-added products based on previously approved drugs. The company's aim is to improve efficacy, safety, and delivery profiles with the goal of increasing clinical value and decreasing the timeline to regulatory approval. Pharma Two B's lead product candidate, P2B001, is being investigated as a treatment for early-stage Parkinson's disease. P2B001 has shown remarkable results in phase-2 clinical trials (149 patients) and is currently undergoing phase-3 clinical trials.
Identity
| Name | Pharma Two B |
|---|---|
| Slug | pharma-two-b |
| Type / kind | startup |
| Crunchbase ID | pharma-two-b |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6n6J0IDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2025 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Prof. Haim Pekeris St 3, Rehovot, Israel |
Web & social
| https://www.linkedin.com/company/80219257 | |
| YouTube | https://www.youtube.com/channel/UCNr7iqFWkwhLez12CJE6cFg |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business models
B2B
Tags
therapeuticspharmaceuticalssustained-releasedrug-discoverybiotechnologyparkinsoncancerpharma-companiesdrug-development
Funding
| Total raised | $46.1M |
|---|---|
| Current stage | Series C |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}